Actelion says wins Japanese approval for heart and lung drug


26 Mar, 2015 3:59 pm

TOKYO – Actelion said on Thursday theJapanese health regulator approved Opsumit, its new treatment for pulmonary arterial hypertension (PAH).

The Swiss firm’s drug has already won approval in the United States and Europe. – Reuters




Must Watch